Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Testosterone | 87 | 2024 | 2494 | 5.740 |
Why?
|
Delirium | 37 | 2024 | 1707 | 2.780 |
Why?
|
Androgens | 31 | 2023 | 1279 | 2.620 |
Why?
|
Hypogonadism | 16 | 2024 | 801 | 2.400 |
Why?
|
Mobility Limitation | 25 | 2023 | 408 | 2.300 |
Why?
|
Sex Hormone-Binding Globulin | 21 | 2024 | 558 | 2.220 |
Why?
|
Muscle Strength | 18 | 2023 | 637 | 1.740 |
Why?
|
Sarcopenia | 11 | 2021 | 378 | 1.650 |
Why?
|
Erectile Dysfunction | 12 | 2024 | 437 | 1.570 |
Why?
|
Accidental Falls | 16 | 2021 | 1078 | 1.560 |
Why?
|
Body Composition | 25 | 2024 | 2439 | 1.520 |
Why?
|
Hand Strength | 12 | 2020 | 462 | 1.510 |
Why?
|
Aging | 35 | 2024 | 8731 | 1.480 |
Why?
|
Estradiol | 16 | 2024 | 1947 | 1.400 |
Why?
|
Hormone Replacement Therapy | 15 | 2024 | 753 | 1.400 |
Why?
|
Estrone | 9 | 2018 | 234 | 1.370 |
Why?
|
Geriatric Assessment | 16 | 2023 | 1429 | 1.050 |
Why?
|
Androgen Antagonists | 7 | 2024 | 1411 | 1.010 |
Why?
|
Walking | 9 | 2021 | 1198 | 0.990 |
Why?
|
Gait | 13 | 2023 | 820 | 0.950 |
Why?
|
Aged | 184 | 2024 | 171117 | 0.890 |
Why?
|
Muscle, Skeletal | 15 | 2024 | 4958 | 0.860 |
Why?
|
Postural Balance | 10 | 2020 | 637 | 0.860 |
Why?
|
Independent Living | 18 | 2023 | 585 | 0.840 |
Why?
|
Frail Elderly | 5 | 2023 | 785 | 0.730 |
Why?
|
Recovery of Function | 6 | 2020 | 2966 | 0.710 |
Why?
|
Gait Disorders, Neurologic | 2 | 2021 | 246 | 0.680 |
Why?
|
Muscle Weakness | 6 | 2020 | 413 | 0.670 |
Why?
|
Bone Density | 14 | 2018 | 3491 | 0.670 |
Why?
|
Male | 199 | 2024 | 363698 | 0.650 |
Why?
|
Phosphodiesterase 5 Inhibitors | 4 | 2013 | 103 | 0.650 |
Why?
|
Prediabetic State | 1 | 2024 | 548 | 0.590 |
Why?
|
Femur | 3 | 2008 | 1310 | 0.570 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 2017 | 43 | 0.550 |
Why?
|
Gonadal Steroid Hormones | 5 | 2023 | 705 | 0.540 |
Why?
|
Postoperative Complications | 23 | 2024 | 15747 | 0.540 |
Why?
|
Insulin Resistance | 8 | 2024 | 3985 | 0.530 |
Why?
|
Dementia | 7 | 2022 | 2744 | 0.530 |
Why?
|
Aged, 80 and over | 66 | 2024 | 59489 | 0.520 |
Why?
|
Humans | 241 | 2024 | 765968 | 0.510 |
Why?
|
Patient Readmission | 6 | 2021 | 3286 | 0.510 |
Why?
|
Luteinizing Hormone | 8 | 2024 | 826 | 0.480 |
Why?
|
Prospective Studies | 55 | 2024 | 54802 | 0.470 |
Why?
|
Hip Fractures | 4 | 2020 | 997 | 0.470 |
Why?
|
Prostatic Neoplasms | 8 | 2024 | 11083 | 0.470 |
Why?
|
Double-Blind Method | 32 | 2024 | 12437 | 0.450 |
Why?
|
Exercise | 8 | 2020 | 5937 | 0.450 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 4 | 2018 | 694 | 0.440 |
Why?
|
Cross-Sectional Studies | 40 | 2024 | 26318 | 0.440 |
Why?
|
Longitudinal Studies | 23 | 2023 | 14751 | 0.440 |
Why?
|
Genes, Y-Linked | 1 | 2013 | 12 | 0.430 |
Why?
|
Cerebrovascular Circulation | 4 | 2017 | 2674 | 0.430 |
Why?
|
Pacemaker, Artificial | 2 | 2017 | 827 | 0.430 |
Why?
|
Middle Aged | 100 | 2024 | 223009 | 0.420 |
Why?
|
Malnutrition | 1 | 2020 | 629 | 0.420 |
Why?
|
Research Design | 8 | 2024 | 6209 | 0.400 |
Why?
|
Activities of Daily Living | 8 | 2023 | 2415 | 0.400 |
Why?
|
Kyphosis | 4 | 2019 | 251 | 0.390 |
Why?
|
Analgesics, Opioid | 8 | 2022 | 3835 | 0.390 |
Why?
|
Absorptiometry, Photon | 13 | 2021 | 1707 | 0.390 |
Why?
|
Andropause | 2 | 2008 | 8 | 0.380 |
Why?
|
Motor Activity | 2 | 2012 | 2704 | 0.380 |
Why?
|
Dietary Proteins | 5 | 2021 | 959 | 0.370 |
Why?
|
Models, Statistical | 3 | 2020 | 5089 | 0.370 |
Why?
|
Dihydrotestosterone | 4 | 2024 | 193 | 0.360 |
Why?
|
Ataxia | 3 | 2017 | 307 | 0.350 |
Why?
|
Dietary Supplements | 7 | 2020 | 3425 | 0.350 |
Why?
|
Retinoscopy | 1 | 2010 | 27 | 0.340 |
Why?
|
Cardiovascular Diseases | 18 | 2024 | 15652 | 0.340 |
Why?
|
Chromatography, Liquid | 6 | 2013 | 990 | 0.340 |
Why?
|
Body Mass Index | 19 | 2024 | 13039 | 0.330 |
Why?
|
Arrhythmias, Cardiac | 2 | 2017 | 2247 | 0.320 |
Why?
|
Female | 109 | 2024 | 396112 | 0.320 |
Why?
|
Thoracic Vertebrae | 3 | 2019 | 614 | 0.310 |
Why?
|
Refraction, Ocular | 1 | 2010 | 188 | 0.310 |
Why?
|
Consensus | 5 | 2020 | 3202 | 0.300 |
Why?
|
Refractive Errors | 1 | 2010 | 148 | 0.300 |
Why?
|
Weight Loss | 3 | 2016 | 2710 | 0.300 |
Why?
|
Life Style | 6 | 2024 | 3926 | 0.290 |
Why?
|
Boston | 18 | 2023 | 9338 | 0.290 |
Why?
|
Cohort Studies | 27 | 2024 | 41649 | 0.280 |
Why?
|
Alzheimer Disease | 7 | 2024 | 8730 | 0.280 |
Why?
|
Gastric Bypass | 1 | 2016 | 820 | 0.280 |
Why?
|
Tandem Mass Spectrometry | 6 | 2013 | 1192 | 0.280 |
Why?
|
Defibrillators, Implantable | 1 | 2017 | 1490 | 0.280 |
Why?
|
Cognition | 12 | 2023 | 7049 | 0.270 |
Why?
|
Antihypertensive Agents | 2 | 2023 | 2033 | 0.270 |
Why?
|
Intra-Abdominal Fat | 2 | 2023 | 623 | 0.270 |
Why?
|
Hysterectomy | 3 | 2019 | 864 | 0.270 |
Why?
|
Adult | 71 | 2024 | 223044 | 0.260 |
Why?
|
Sulfones | 3 | 2013 | 447 | 0.260 |
Why?
|
Femur Neck | 5 | 2018 | 316 | 0.260 |
Why?
|
Massachusetts | 11 | 2022 | 8875 | 0.260 |
Why?
|
Cognition Disorders | 5 | 2018 | 3967 | 0.250 |
Why?
|
Libido | 1 | 2006 | 123 | 0.250 |
Why?
|
Risk Factors | 38 | 2024 | 74840 | 0.250 |
Why?
|
Health Status | 8 | 2018 | 4080 | 0.240 |
Why?
|
Fontan Procedure | 4 | 2012 | 805 | 0.240 |
Why?
|
Obesity, Morbid | 1 | 2016 | 1292 | 0.240 |
Why?
|
Tai Ji | 2 | 2019 | 289 | 0.230 |
Why?
|
Age Factors | 16 | 2024 | 18380 | 0.230 |
Why?
|
Quality of Life | 13 | 2023 | 13462 | 0.230 |
Why?
|
Remission, Spontaneous | 3 | 2011 | 386 | 0.220 |
Why?
|
Geriatric Nursing | 2 | 2021 | 39 | 0.220 |
Why?
|
Physicians | 1 | 2022 | 4588 | 0.220 |
Why?
|
Leg Injuries | 4 | 2007 | 179 | 0.220 |
Why?
|
Disability Evaluation | 4 | 2020 | 1820 | 0.220 |
Why?
|
Interleukin-6 | 3 | 2024 | 3222 | 0.210 |
Why?
|
Erythropoietin | 3 | 2018 | 716 | 0.210 |
Why?
|
Prevalence | 12 | 2020 | 15842 | 0.210 |
Why?
|
Atrophy | 3 | 2024 | 1635 | 0.210 |
Why?
|
5-alpha Reductase Inhibitors | 2 | 2016 | 114 | 0.210 |
Why?
|
Incidence | 14 | 2024 | 21480 | 0.210 |
Why?
|
Biostatistics | 1 | 2024 | 162 | 0.210 |
Why?
|
Socioeconomic Factors | 8 | 2024 | 7838 | 0.210 |
Why?
|
Urinary Retention | 1 | 2023 | 100 | 0.210 |
Why?
|
Severity of Illness Index | 12 | 2023 | 15880 | 0.210 |
Why?
|
Fluoroimmunoassay | 2 | 2013 | 30 | 0.210 |
Why?
|
Fractures, Bone | 4 | 2022 | 2041 | 0.200 |
Why?
|
Hospitalization | 11 | 2022 | 10808 | 0.200 |
Why?
|
Erythropoiesis | 2 | 2018 | 691 | 0.200 |
Why?
|
Exercise Test | 5 | 2020 | 2180 | 0.190 |
Why?
|
Psychometrics | 4 | 2022 | 3062 | 0.190 |
Why?
|
Adipose Tissue | 3 | 2023 | 3312 | 0.190 |
Why?
|
Follow-Up Studies | 18 | 2019 | 39193 | 0.190 |
Why?
|
Oxygen Consumption | 3 | 2018 | 1870 | 0.190 |
Why?
|
Liver | 4 | 2024 | 7562 | 0.190 |
Why?
|
Administration, Cutaneous | 7 | 2020 | 715 | 0.190 |
Why?
|
Ergocalciferols | 2 | 2013 | 105 | 0.190 |
Why?
|
Logistic Models | 12 | 2020 | 13266 | 0.190 |
Why?
|
Health Education | 2 | 2019 | 1060 | 0.190 |
Why?
|
Reference Values | 7 | 2017 | 4908 | 0.180 |
Why?
|
Polycythemia | 2 | 2013 | 125 | 0.180 |
Why?
|
Depression | 8 | 2024 | 8237 | 0.180 |
Why?
|
Loneliness | 1 | 2023 | 211 | 0.180 |
Why?
|
Physical Fitness | 3 | 2020 | 742 | 0.180 |
Why?
|
Estrogens | 3 | 2012 | 1529 | 0.180 |
Why?
|
Lower Extremity | 3 | 2019 | 1226 | 0.170 |
Why?
|
C-Reactive Protein | 3 | 2024 | 3850 | 0.170 |
Why?
|
Vitamin D | 6 | 2018 | 3272 | 0.170 |
Why?
|
Cerebral Cortex | 3 | 2024 | 5767 | 0.170 |
Why?
|
Multivariate Analysis | 11 | 2017 | 12056 | 0.170 |
Why?
|
Affect | 3 | 2018 | 1500 | 0.170 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2024 | 10383 | 0.170 |
Why?
|
Geriatrics | 1 | 2024 | 396 | 0.170 |
Why?
|
Confidence Intervals | 6 | 2011 | 2910 | 0.170 |
Why?
|
Baltimore | 1 | 2020 | 232 | 0.170 |
Why?
|
Aspirin | 2 | 2022 | 3134 | 0.170 |
Why?
|
Health Surveys | 7 | 2020 | 4056 | 0.160 |
Why?
|
Polymorphism, Genetic | 1 | 2010 | 4247 | 0.160 |
Why?
|
Gels | 5 | 2023 | 419 | 0.160 |
Why?
|
Antimicrobial Cationic Peptides | 2 | 2013 | 348 | 0.160 |
Why?
|
Dose-Response Relationship, Drug | 10 | 2019 | 10729 | 0.160 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 2 | 2017 | 75 | 0.160 |
Why?
|
Risk Assessment | 14 | 2021 | 24282 | 0.160 |
Why?
|
Bone Remodeling | 2 | 2017 | 577 | 0.160 |
Why?
|
Treatment Outcome | 24 | 2024 | 65188 | 0.160 |
Why?
|
Nurse's Role | 1 | 2020 | 187 | 0.160 |
Why?
|
Hydrocortisone | 1 | 2007 | 1827 | 0.160 |
Why?
|
Osteoporosis | 3 | 2018 | 1582 | 0.150 |
Why?
|
Placebos | 5 | 2018 | 1659 | 0.150 |
Why?
|
Leuprolide | 2 | 2018 | 312 | 0.150 |
Why?
|
Medication Reconciliation | 1 | 2020 | 153 | 0.150 |
Why?
|
Health Services for the Aged | 1 | 2021 | 265 | 0.150 |
Why?
|
Leg | 1 | 2023 | 1080 | 0.150 |
Why?
|
Nursing Homes | 3 | 2022 | 1084 | 0.150 |
Why?
|
Piperazines | 3 | 2013 | 2549 | 0.150 |
Why?
|
Lumbar Vertebrae | 4 | 2019 | 1873 | 0.150 |
Why?
|
Radius | 3 | 2011 | 440 | 0.140 |
Why?
|
Eunuchism | 1 | 2017 | 19 | 0.140 |
Why?
|
Europe | 2 | 2017 | 3423 | 0.140 |
Why?
|
Aromatase | 1 | 2018 | 147 | 0.140 |
Why?
|
Receptors, Androgen | 3 | 2016 | 1088 | 0.140 |
Why?
|
Agrin | 1 | 2017 | 75 | 0.140 |
Why?
|
Disease Progression | 8 | 2018 | 13632 | 0.140 |
Why?
|
Neuropsychological Tests | 7 | 2020 | 7123 | 0.140 |
Why?
|
Confusion | 2 | 2016 | 277 | 0.140 |
Why?
|
Patient Care Management | 1 | 2020 | 303 | 0.140 |
Why?
|
Pharmacoepidemiology | 1 | 2020 | 351 | 0.140 |
Why?
|
Ankle | 1 | 2020 | 353 | 0.140 |
Why?
|
Predictive Value of Tests | 9 | 2020 | 15398 | 0.130 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2018 | 291 | 0.130 |
Why?
|
Wounds and Injuries | 3 | 2018 | 2511 | 0.130 |
Why?
|
Prostatectomy | 1 | 2024 | 1782 | 0.130 |
Why?
|
Reference Standards | 2 | 2017 | 1013 | 0.130 |
Why?
|
Antineoplastic Agents, Hormonal | 3 | 2023 | 1534 | 0.130 |
Why?
|
Long-Term Care | 1 | 2020 | 629 | 0.130 |
Why?
|
Gonadotrophs | 1 | 2016 | 19 | 0.130 |
Why?
|
Cause of Death | 2 | 2024 | 3708 | 0.130 |
Why?
|
Public Housing | 1 | 2017 | 140 | 0.130 |
Why?
|
Spinal Curvatures | 1 | 2016 | 71 | 0.130 |
Why?
|
Pain Perception | 1 | 2017 | 198 | 0.130 |
Why?
|
Finasteride | 1 | 2016 | 86 | 0.120 |
Why?
|
Mental Health | 3 | 2023 | 3278 | 0.120 |
Why?
|
Endocrine System Diseases | 2 | 2008 | 243 | 0.120 |
Why?
|
Reproducibility of Results | 8 | 2022 | 20124 | 0.120 |
Why?
|
Time Factors | 13 | 2024 | 40065 | 0.120 |
Why?
|
Mortality | 3 | 2020 | 2904 | 0.120 |
Why?
|
Motor Skills | 1 | 2018 | 516 | 0.120 |
Why?
|
Inflammation | 6 | 2024 | 10850 | 0.120 |
Why?
|
Resistance Training | 1 | 2017 | 196 | 0.120 |
Why?
|
Blood Chemical Analysis | 1 | 2017 | 433 | 0.120 |
Why?
|
Craniocerebral Trauma | 1 | 2019 | 494 | 0.120 |
Why?
|
Accidents, Home | 1 | 2015 | 73 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 747 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 13 | 2024 | 36532 | 0.120 |
Why?
|
Heart Defects, Congenital | 4 | 2012 | 4697 | 0.120 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2016 | 193 | 0.120 |
Why?
|
Videoconferencing | 1 | 2017 | 209 | 0.120 |
Why?
|
Sensory Aids | 1 | 2014 | 40 | 0.120 |
Why?
|
Institutionalization | 1 | 2015 | 108 | 0.120 |
Why?
|
United States | 18 | 2022 | 72903 | 0.120 |
Why?
|
Inheritance Patterns | 1 | 2016 | 345 | 0.110 |
Why?
|
Cardiovascular System | 1 | 2021 | 841 | 0.110 |
Why?
|
Orthopedic Procedures | 3 | 2020 | 1280 | 0.110 |
Why?
|
Shoes | 1 | 2014 | 90 | 0.110 |
Why?
|
Patients | 1 | 2020 | 910 | 0.110 |
Why?
|
Anemia | 1 | 2023 | 1511 | 0.110 |
Why?
|
Vascular Resistance | 1 | 2017 | 941 | 0.110 |
Why?
|
Football | 1 | 2019 | 504 | 0.110 |
Why?
|
Motor Cortex | 1 | 2021 | 1003 | 0.110 |
Why?
|
Health Services Research | 1 | 2021 | 1808 | 0.110 |
Why?
|
Diet Records | 1 | 2015 | 425 | 0.110 |
Why?
|
Spleen | 2 | 2017 | 2296 | 0.110 |
Why?
|
Catastrophization | 1 | 2017 | 352 | 0.110 |
Why?
|
Young Adult | 14 | 2024 | 59889 | 0.110 |
Why?
|
Analgesics | 1 | 2020 | 1060 | 0.110 |
Why?
|
Glucose | 2 | 2024 | 4335 | 0.110 |
Why?
|
Comorbidity | 6 | 2019 | 10563 | 0.110 |
Why?
|
Health Care Costs | 3 | 2022 | 3242 | 0.110 |
Why?
|
Nutrition Assessment | 1 | 2017 | 738 | 0.110 |
Why?
|
Prostate | 3 | 2023 | 1755 | 0.110 |
Why?
|
Follicle Stimulating Hormone | 2 | 2016 | 731 | 0.110 |
Why?
|
Aorta, Abdominal | 1 | 2016 | 596 | 0.100 |
Why?
|
Interview, Psychological | 1 | 2016 | 812 | 0.100 |
Why?
|
Self Report | 2 | 2022 | 3770 | 0.100 |
Why?
|
Telephone | 1 | 2016 | 627 | 0.100 |
Why?
|
Sexual Dysfunction, Physiological | 3 | 2016 | 363 | 0.100 |
Why?
|
Cytokines | 2 | 2018 | 7421 | 0.100 |
Why?
|
Limb Salvage | 2 | 2008 | 488 | 0.100 |
Why?
|
Monitoring, Ambulatory | 1 | 2016 | 357 | 0.100 |
Why?
|
Body Height | 2 | 2010 | 1562 | 0.100 |
Why?
|
Models, Biological | 2 | 2011 | 9443 | 0.100 |
Why?
|
Vibration | 1 | 2014 | 334 | 0.100 |
Why?
|
Sexuality | 1 | 2014 | 180 | 0.100 |
Why?
|
25-Hydroxyvitamin D 2 | 1 | 2012 | 38 | 0.100 |
Why?
|
Models, Chemical | 1 | 2014 | 608 | 0.100 |
Why?
|
Body Weight | 5 | 2013 | 4622 | 0.100 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2015 | 429 | 0.100 |
Why?
|
Heart Bypass, Right | 1 | 2012 | 75 | 0.100 |
Why?
|
Noise | 1 | 2014 | 296 | 0.100 |
Why?
|
Azasteroids | 1 | 2012 | 37 | 0.100 |
Why?
|
Alopecia | 1 | 2016 | 414 | 0.100 |
Why?
|
Length of Stay | 5 | 2020 | 6485 | 0.100 |
Why?
|
Diuretics | 1 | 2015 | 613 | 0.100 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5891 | 0.100 |
Why?
|
Postoperative Care | 2 | 2016 | 1470 | 0.100 |
Why?
|
Calcium Channel Blockers | 1 | 2015 | 686 | 0.100 |
Why?
|
Blood Glucose | 4 | 2021 | 6424 | 0.100 |
Why?
|
Adiposity | 2 | 2012 | 1890 | 0.090 |
Why?
|
Regional Blood Flow | 1 | 2015 | 1478 | 0.090 |
Why?
|
Calcitriol | 1 | 2013 | 299 | 0.090 |
Why?
|
Caregivers | 2 | 2021 | 2307 | 0.090 |
Why?
|
Calcifediol | 1 | 2012 | 156 | 0.090 |
Why?
|
Bone Density Conservation Agents | 1 | 2018 | 791 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 2268 | 0.090 |
Why?
|
Diet Surveys | 1 | 2015 | 1159 | 0.090 |
Why?
|
Dyslipidemias | 1 | 2018 | 869 | 0.090 |
Why?
|
Anabolic Agents | 1 | 2013 | 256 | 0.090 |
Why?
|
Chemistry, Clinical | 1 | 2011 | 64 | 0.090 |
Why?
|
Radius Fractures | 1 | 2017 | 516 | 0.090 |
Why?
|
Atherosclerosis | 2 | 2018 | 3424 | 0.090 |
Why?
|
Vitamin D Deficiency | 2 | 2012 | 1348 | 0.090 |
Why?
|
Physical Therapy Modalities | 1 | 2014 | 533 | 0.090 |
Why?
|
Ankle Brachial Index | 1 | 2011 | 166 | 0.090 |
Why?
|
Optometry | 1 | 2010 | 29 | 0.090 |
Why?
|
Testis | 1 | 2013 | 780 | 0.080 |
Why?
|
Executive Function | 2 | 2018 | 1391 | 0.080 |
Why?
|
Continuity of Patient Care | 1 | 2017 | 1078 | 0.080 |
Why?
|
Accommodation, Ocular | 1 | 2010 | 47 | 0.080 |
Why?
|
Impotence, Vasculogenic | 1 | 2009 | 13 | 0.080 |
Why?
|
Isoflavones | 1 | 2010 | 139 | 0.080 |
Why?
|
Aorta, Thoracic | 1 | 2016 | 1103 | 0.080 |
Why?
|
Protein Multimerization | 1 | 2014 | 959 | 0.080 |
Why?
|
Fatigue | 2 | 2018 | 1549 | 0.080 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2015 | 1237 | 0.080 |
Why?
|
Lung | 2 | 2018 | 10033 | 0.080 |
Why?
|
Trinucleotide Repeats | 1 | 2010 | 258 | 0.080 |
Why?
|
Mexico | 1 | 2011 | 777 | 0.080 |
Why?
|
Hypertension | 5 | 2023 | 8626 | 0.080 |
Why?
|
Outpatients | 1 | 2017 | 1595 | 0.080 |
Why?
|
Eyeglasses | 1 | 2010 | 138 | 0.080 |
Why?
|
Allied Health Personnel | 1 | 2010 | 156 | 0.080 |
Why?
|
Antipsychotic Agents | 1 | 2022 | 3076 | 0.080 |
Why?
|
Growth Hormone | 1 | 2010 | 566 | 0.080 |
Why?
|
Family Health | 1 | 2013 | 1253 | 0.080 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 1514 | 0.070 |
Why?
|
Disease Susceptibility | 1 | 2015 | 1789 | 0.070 |
Why?
|
Heart Ventricles | 2 | 2010 | 3832 | 0.070 |
Why?
|
Odds Ratio | 4 | 2017 | 9649 | 0.070 |
Why?
|
Cluster Analysis | 4 | 2021 | 2721 | 0.070 |
Why?
|
Norwood Procedures | 1 | 2010 | 192 | 0.070 |
Why?
|
Regression Analysis | 4 | 2013 | 6322 | 0.070 |
Why?
|
Peptide Fragments | 2 | 2017 | 5125 | 0.070 |
Why?
|
Iron | 2 | 2015 | 1816 | 0.070 |
Why?
|
Thinness | 1 | 2011 | 482 | 0.070 |
Why?
|
Linear Models | 5 | 2019 | 5876 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2023 | 12240 | 0.070 |
Why?
|
Cholecalciferol | 1 | 2013 | 550 | 0.070 |
Why?
|
Electroencephalography | 2 | 2022 | 6273 | 0.070 |
Why?
|
Coronary Vessels | 2 | 2016 | 3096 | 0.070 |
Why?
|
Phenotype | 2 | 2023 | 16721 | 0.070 |
Why?
|
Bone Resorption | 1 | 2011 | 717 | 0.070 |
Why?
|
Reproduction | 1 | 2012 | 641 | 0.070 |
Why?
|
Hyperlipidemias | 2 | 2010 | 770 | 0.070 |
Why?
|
Sleep | 1 | 2023 | 4813 | 0.070 |
Why?
|
Hemoglobins | 3 | 2023 | 1530 | 0.070 |
Why?
|
Compressive Strength | 1 | 2008 | 159 | 0.070 |
Why?
|
Autoantibodies | 1 | 2016 | 2113 | 0.070 |
Why?
|
Poverty | 1 | 2019 | 2714 | 0.070 |
Why?
|
Parkinson Disease | 1 | 2021 | 2895 | 0.070 |
Why?
|
Brazil | 1 | 2011 | 1248 | 0.070 |
Why?
|
Adolescent | 15 | 2024 | 88835 | 0.070 |
Why?
|
Population Groups | 1 | 2008 | 209 | 0.070 |
Why?
|
Diffusion Tensor Imaging | 1 | 2017 | 2410 | 0.070 |
Why?
|
Work Capacity Evaluation | 1 | 2006 | 42 | 0.070 |
Why?
|
Psychomotor Performance | 1 | 2015 | 1881 | 0.070 |
Why?
|
Hip | 1 | 2008 | 249 | 0.070 |
Why?
|
Medicare | 2 | 2022 | 6823 | 0.070 |
Why?
|
Physical Endurance | 1 | 2008 | 368 | 0.060 |
Why?
|
Endocrine System | 1 | 2006 | 111 | 0.060 |
Why?
|
Epidemiologic Methods | 2 | 2009 | 1326 | 0.060 |
Why?
|
Urination Disorders | 1 | 2007 | 236 | 0.060 |
Why?
|
Feasibility Studies | 1 | 2017 | 5302 | 0.060 |
Why?
|
Hepatocytes | 1 | 2013 | 1247 | 0.060 |
Why?
|
Heart | 1 | 2019 | 4414 | 0.060 |
Why?
|
Chronic Disease | 2 | 2019 | 9347 | 0.060 |
Why?
|
Exercise Tolerance | 1 | 2010 | 841 | 0.060 |
Why?
|
Down-Regulation | 2 | 2010 | 2927 | 0.060 |
Why?
|
Work | 1 | 2006 | 195 | 0.060 |
Why?
|
Sweden | 2 | 2018 | 1381 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14652 | 0.060 |
Why?
|
Cytosine | 1 | 2006 | 213 | 0.060 |
Why?
|
Likelihood Functions | 1 | 2008 | 993 | 0.060 |
Why?
|
Guanine | 1 | 2006 | 282 | 0.060 |
Why?
|
Energy Intake | 3 | 2017 | 2141 | 0.060 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2010 | 595 | 0.060 |
Why?
|
Dehydroepiandrosterone | 1 | 2005 | 248 | 0.060 |
Why?
|
Hip Joint | 1 | 2011 | 1000 | 0.060 |
Why?
|
Blood Pressure | 2 | 2023 | 8532 | 0.060 |
Why?
|
Obesity | 5 | 2023 | 13076 | 0.060 |
Why?
|
Myocardial Infarction | 2 | 2023 | 11499 | 0.060 |
Why?
|
Injury Severity Score | 1 | 2008 | 1050 | 0.060 |
Why?
|
Hypolipidemic Agents | 1 | 2009 | 608 | 0.060 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2006 | 780 | 0.060 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2741 | 0.060 |
Why?
|
Erythrocytes | 1 | 2013 | 2395 | 0.050 |
Why?
|
Evidence-Based Medicine | 2 | 2020 | 3685 | 0.050 |
Why?
|
Transdermal Patch | 1 | 2023 | 51 | 0.050 |
Why?
|
Prognosis | 3 | 2018 | 29922 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2013 | 3715 | 0.050 |
Why?
|
Prenatal Diagnosis | 1 | 2010 | 1268 | 0.050 |
Why?
|
Estrogen Replacement Therapy | 1 | 2009 | 1206 | 0.050 |
Why?
|
Gene Frequency | 1 | 2010 | 3624 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2010 | 1936 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3100 | 0.050 |
Why?
|
Upper Extremity | 1 | 2008 | 682 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3223 | 0.050 |
Why?
|
Attitude to Health | 1 | 2011 | 2020 | 0.050 |
Why?
|
Safety | 1 | 2007 | 1157 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2016 | 4034 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5370 | 0.050 |
Why?
|
Osteocalcin | 2 | 2017 | 271 | 0.050 |
Why?
|
Breast Neoplasms | 1 | 2009 | 21056 | 0.050 |
Why?
|
Metabolism | 2 | 2016 | 193 | 0.050 |
Why?
|
Single-Blind Method | 2 | 2017 | 1589 | 0.050 |
Why?
|
Ovariectomy | 2 | 2014 | 611 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2020 | 5189 | 0.050 |
Why?
|
Extremities | 2 | 2017 | 869 | 0.050 |
Why?
|
Quality Improvement | 1 | 2017 | 3853 | 0.050 |
Why?
|
Kidney | 1 | 2017 | 7066 | 0.050 |
Why?
|
Acceleration | 1 | 2022 | 187 | 0.050 |
Why?
|
National Institute on Aging (U.S.) | 1 | 2021 | 40 | 0.050 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2012 | 2136 | 0.050 |
Why?
|
Data Interpretation, Statistical | 2 | 2008 | 2686 | 0.050 |
Why?
|
Hepatitis C | 1 | 2011 | 1597 | 0.050 |
Why?
|
Age Distribution | 3 | 2016 | 2858 | 0.050 |
Why?
|
Heart Function Tests | 2 | 2012 | 317 | 0.050 |
Why?
|
Multilevel Analysis | 1 | 2021 | 148 | 0.040 |
Why?
|
Statistics as Topic | 2 | 2017 | 2352 | 0.040 |
Why?
|
Hemodynamics | 1 | 2011 | 4184 | 0.040 |
Why?
|
Organ Size | 2 | 2017 | 2260 | 0.040 |
Why?
|
Gene Expression Regulation | 3 | 2018 | 11888 | 0.040 |
Why?
|
Adenine | 1 | 2006 | 994 | 0.040 |
Why?
|
Adult Children | 1 | 2020 | 104 | 0.040 |
Why?
|
Stroke Volume | 2 | 2012 | 5596 | 0.040 |
Why?
|
Anticholesteremic Agents | 1 | 2007 | 970 | 0.040 |
Why?
|
Rehabilitation | 1 | 2021 | 125 | 0.040 |
Why?
|
Selection Bias | 1 | 2022 | 361 | 0.040 |
Why?
|
Employment | 1 | 2006 | 1106 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 20659 | 0.040 |
Why?
|
Herpes Zoster | 1 | 2002 | 252 | 0.040 |
Why?
|
Sex Factors | 3 | 2020 | 10603 | 0.040 |
Why?
|
Visual Acuity | 1 | 2010 | 2708 | 0.040 |
Why?
|
Peripheral Arterial Disease | 1 | 2011 | 1311 | 0.040 |
Why?
|
HIV Infections | 2 | 2020 | 17533 | 0.040 |
Why?
|
Sexual Behavior | 2 | 2024 | 2193 | 0.040 |
Why?
|
Men's Health | 1 | 2020 | 75 | 0.040 |
Why?
|
Australia | 2 | 2015 | 1258 | 0.040 |
Why?
|
Purines | 2 | 2013 | 615 | 0.040 |
Why?
|
Blood Pressure Determination | 1 | 2023 | 647 | 0.040 |
Why?
|
Housing for the Elderly | 1 | 2019 | 17 | 0.040 |
Why?
|
Educational Status | 1 | 2007 | 2513 | 0.040 |
Why?
|
Personality Inventory | 1 | 2002 | 1018 | 0.040 |
Why?
|
Collagen Type I | 2 | 2017 | 615 | 0.040 |
Why?
|
Brain | 2 | 2017 | 27171 | 0.040 |
Why?
|
Medical Errors | 1 | 2007 | 1260 | 0.040 |
Why?
|
Insulin | 3 | 2018 | 6599 | 0.040 |
Why?
|
Depressive Disorder, Major | 1 | 2016 | 4808 | 0.040 |
Why?
|
Remote Sensing Technology | 1 | 2019 | 93 | 0.040 |
Why?
|
Pelvic Floor | 1 | 2019 | 138 | 0.040 |
Why?
|
Menopause, Premature | 1 | 2019 | 124 | 0.040 |
Why?
|
Erythrocyte Count | 1 | 2018 | 158 | 0.040 |
Why?
|
Program Evaluation | 1 | 2007 | 2499 | 0.040 |
Why?
|
Cross-Over Studies | 3 | 2014 | 2108 | 0.040 |
Why?
|
Pandemics | 3 | 2023 | 8703 | 0.040 |
Why?
|
Retirement | 1 | 2019 | 198 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 11840 | 0.040 |
Why?
|
Ventricular Function, Left | 1 | 2010 | 3928 | 0.040 |
Why?
|
Education, Medical, Undergraduate | 1 | 2007 | 1085 | 0.040 |
Why?
|
Interleukin-1beta | 1 | 2023 | 1028 | 0.040 |
Why?
|
Lung Volume Measurements | 1 | 2018 | 381 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 1 | 2011 | 3230 | 0.040 |
Why?
|
Vitamins | 2 | 2018 | 1630 | 0.030 |
Why?
|
Students, Medical | 2 | 2007 | 1959 | 0.030 |
Why?
|
Supine Position | 1 | 2017 | 209 | 0.030 |
Why?
|
Internship and Residency | 2 | 2007 | 5946 | 0.030 |
Why?
|
Temperature | 1 | 2023 | 2226 | 0.030 |
Why?
|
Teriparatide | 1 | 2018 | 225 | 0.030 |
Why?
|
Procollagen | 1 | 2017 | 189 | 0.030 |
Why?
|
Intelligence Tests | 1 | 2017 | 504 | 0.030 |
Why?
|
Solubility | 1 | 2018 | 1078 | 0.030 |
Why?
|
Hyperalgesia | 1 | 2000 | 514 | 0.030 |
Why?
|
Chromosomes, Human, X | 1 | 2018 | 319 | 0.030 |
Why?
|
Benzodiazepines | 1 | 2022 | 1136 | 0.030 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2007 | 238 | 0.030 |
Why?
|
Ferritins | 1 | 2018 | 600 | 0.030 |
Why?
|
Neuralgia | 1 | 2002 | 625 | 0.030 |
Why?
|
Financing, Government | 1 | 2019 | 473 | 0.030 |
Why?
|
New South Wales | 1 | 2015 | 69 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2016 | 6014 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2020 | 1370 | 0.030 |
Why?
|
Infection Control | 1 | 2022 | 983 | 0.030 |
Why?
|
Self-Assessment | 1 | 2017 | 400 | 0.030 |
Why?
|
Ankle Joint | 1 | 2019 | 450 | 0.030 |
Why?
|
Internet | 1 | 2007 | 3106 | 0.030 |
Why?
|
Lipids | 2 | 2018 | 3315 | 0.030 |
Why?
|
Feedback, Sensory | 1 | 2014 | 58 | 0.030 |
Why?
|
Pilot Projects | 2 | 2022 | 8733 | 0.030 |
Why?
|
Pain Measurement | 3 | 2017 | 3561 | 0.030 |
Why?
|
Eflornithine | 1 | 2013 | 31 | 0.030 |
Why?
|
Thiamine | 1 | 2015 | 160 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2023 | 1808 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2023 | 2464 | 0.030 |
Why?
|
Phosphorus | 1 | 2015 | 337 | 0.030 |
Why?
|
Primary Health Care | 2 | 2020 | 4736 | 0.030 |
Why?
|
RNA, Viral | 1 | 2022 | 2864 | 0.030 |
Why?
|
Ornithine Decarboxylase | 1 | 2013 | 63 | 0.030 |
Why?
|
Diphosphonates | 1 | 2018 | 625 | 0.030 |
Why?
|
Anthropometry | 1 | 2018 | 1338 | 0.030 |
Why?
|
Middle Cerebral Artery | 1 | 2015 | 268 | 0.030 |
Why?
|
Lipoproteins | 1 | 2018 | 866 | 0.030 |
Why?
|
Alkaline Phosphatase | 1 | 2017 | 854 | 0.030 |
Why?
|
beta Carotene | 1 | 2015 | 522 | 0.030 |
Why?
|
Androstenedione | 1 | 2013 | 138 | 0.030 |
Why?
|
Pain Threshold | 1 | 2017 | 604 | 0.030 |
Why?
|
Diabetes Complications | 2 | 2012 | 1316 | 0.030 |
Why?
|
Movement | 1 | 2020 | 1462 | 0.030 |
Why?
|
Pelvis | 1 | 2018 | 738 | 0.030 |
Why?
|
Sensory Thresholds | 1 | 2014 | 377 | 0.030 |
Why?
|
Blood Flow Velocity | 1 | 2017 | 1381 | 0.030 |
Why?
|
Allosteric Regulation | 1 | 2014 | 425 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2017 | 22223 | 0.030 |
Why?
|
Radioimmunoassay | 1 | 2013 | 860 | 0.030 |
Why?
|
Self Efficacy | 1 | 2017 | 642 | 0.030 |
Why?
|
Follistatin | 1 | 2013 | 138 | 0.030 |
Why?
|
Orgasm | 1 | 2012 | 63 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2020 | 2194 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2020 | 2739 | 0.030 |
Why?
|
Skilled Nursing Facilities | 1 | 2017 | 410 | 0.030 |
Why?
|
Neoplasms | 2 | 2020 | 22340 | 0.030 |
Why?
|
Premenopause | 1 | 2017 | 1037 | 0.030 |
Why?
|
Penile Erection | 1 | 2012 | 100 | 0.030 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2022 | 1496 | 0.030 |
Why?
|
Smad Proteins | 1 | 2013 | 157 | 0.030 |
Why?
|
Preventive Health Services | 1 | 2017 | 570 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2010 | 3432 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 3251 | 0.020 |
Why?
|
Range of Motion, Articular | 1 | 2019 | 1594 | 0.020 |
Why?
|
Sebum | 1 | 2012 | 17 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2017 | 1693 | 0.020 |
Why?
|
Mendelian Randomization Analysis | 1 | 2018 | 1044 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 8041 | 0.020 |
Why?
|
Health Services | 1 | 2017 | 756 | 0.020 |
Why?
|
Vitamin A | 1 | 2015 | 610 | 0.020 |
Why?
|
Coitus | 1 | 2012 | 133 | 0.020 |
Why?
|
Transferrin | 1 | 2013 | 283 | 0.020 |
Why?
|
Trauma Centers | 2 | 2008 | 952 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2010 | 6203 | 0.020 |
Why?
|
Retrospective Studies | 5 | 2022 | 81514 | 0.020 |
Why?
|
Magnesium | 1 | 2015 | 813 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2024 | 3714 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2017 | 932 | 0.020 |
Why?
|
Risk | 2 | 2017 | 9591 | 0.020 |
Why?
|
K562 Cells | 1 | 2013 | 649 | 0.020 |
Why?
|
Survival Analysis | 2 | 2018 | 10070 | 0.020 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2012 | 282 | 0.020 |
Why?
|
Zinc | 1 | 2015 | 675 | 0.020 |
Why?
|
Peptides | 2 | 2017 | 4331 | 0.020 |
Why?
|
Prefrontal Cortex | 1 | 2021 | 2224 | 0.020 |
Why?
|
Hypophysectomy | 1 | 2010 | 113 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2013 | 9550 | 0.020 |
Why?
|
Hematocrit | 1 | 2012 | 621 | 0.020 |
Why?
|
Soybean Proteins | 1 | 2010 | 55 | 0.020 |
Why?
|
Smoking | 2 | 2020 | 9081 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2002 | 2897 | 0.020 |
Why?
|
Knee Joint | 1 | 2019 | 1656 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 2017 | 1789 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2017 | 1432 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1884 | 0.020 |
Why?
|
Urban Health | 1 | 2012 | 530 | 0.020 |
Why?
|
Nutritional Status | 1 | 2018 | 1620 | 0.020 |
Why?
|
Urban Population | 1 | 2017 | 2040 | 0.020 |
Why?
|
Biomedical Research | 1 | 2024 | 3458 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2022 | 3819 | 0.020 |
Why?
|
Ethanol | 1 | 2015 | 1323 | 0.020 |
Why?
|
Observer Variation | 1 | 2015 | 2615 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 2 | 2010 | 6499 | 0.020 |
Why?
|
Orchiectomy | 1 | 2010 | 460 | 0.020 |
Why?
|
Fibrinogen | 1 | 2012 | 895 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3888 | 0.020 |
Why?
|
Parents | 1 | 2022 | 3592 | 0.020 |
Why?
|
Arousal | 1 | 2014 | 1171 | 0.020 |
Why?
|
Receptor, IGF Type 1 | 1 | 2010 | 385 | 0.020 |
Why?
|
Brain Concussion | 1 | 2019 | 1432 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2018 | 16047 | 0.020 |
Why?
|
DNA Methylation | 1 | 2022 | 4424 | 0.020 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2013 | 844 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2011 | 990 | 0.020 |
Why?
|
Intraoperative Care | 1 | 2011 | 760 | 0.020 |
Why?
|
Patient Compliance | 1 | 2017 | 2692 | 0.020 |
Why?
|
Injections | 1 | 2010 | 840 | 0.020 |
Why?
|
Waist-Hip Ratio | 1 | 2008 | 520 | 0.020 |
Why?
|
Cholesterol | 1 | 2016 | 2898 | 0.020 |
Why?
|
Sampling Studies | 1 | 2008 | 607 | 0.020 |
Why?
|
Fatty Liver | 1 | 2013 | 807 | 0.020 |
Why?
|
Child | 5 | 2012 | 80564 | 0.020 |
Why?
|
Algorithms | 2 | 2016 | 14071 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2012 | 1472 | 0.020 |
Why?
|
Postoperative Period | 1 | 2010 | 1816 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2017 | 1880 | 0.020 |
Why?
|
Anxiety | 1 | 2020 | 4671 | 0.020 |
Why?
|
Pulmonary Veins | 1 | 2011 | 757 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3797 | 0.020 |
Why?
|
Postmenopause | 1 | 2014 | 2515 | 0.010 |
Why?
|
California | 1 | 2009 | 1436 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2010 | 1731 | 0.010 |
Why?
|
Heart Atria | 1 | 2011 | 1363 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3356 | 0.010 |
Why?
|
Polypharmacy | 1 | 2007 | 306 | 0.010 |
Why?
|
Kinetics | 1 | 2012 | 6274 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2013 | 6493 | 0.010 |
Why?
|
Patient Discharge | 1 | 2017 | 3461 | 0.010 |
Why?
|
Epidemiologic Studies | 1 | 2007 | 677 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7584 | 0.010 |
Why?
|
Electrocardiography | 1 | 2017 | 6404 | 0.010 |
Why?
|
Risk Management | 1 | 2007 | 559 | 0.010 |
Why?
|
Demography | 1 | 2008 | 1641 | 0.010 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2012 | 1736 | 0.010 |
Why?
|
Genotype | 1 | 2018 | 13024 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2009 | 12509 | 0.010 |
Why?
|
Sex Distribution | 1 | 2008 | 2263 | 0.010 |
Why?
|
Knee | 1 | 2004 | 271 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6309 | 0.010 |
Why?
|
Heart Rate | 1 | 2014 | 4204 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4850 | 0.010 |
Why?
|
Calcium | 1 | 2015 | 5767 | 0.010 |
Why?
|
Sickness Impact Profile | 1 | 2002 | 297 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 3421 | 0.010 |
Why?
|
Mice | 3 | 2013 | 81819 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2011 | 2116 | 0.010 |
Why?
|
Stroke | 1 | 2023 | 9747 | 0.010 |
Why?
|
Mass Screening | 1 | 2016 | 5446 | 0.010 |
Why?
|
Radiography | 1 | 2011 | 6919 | 0.010 |
Why?
|
Schools, Medical | 1 | 2007 | 876 | 0.010 |
Why?
|
Signal Transduction | 2 | 2013 | 23601 | 0.010 |
Why?
|
Educational Measurement | 1 | 2007 | 1260 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2844 | 0.010 |
Why?
|
Social Class | 1 | 2009 | 2007 | 0.010 |
Why?
|
Factor Analysis, Statistical | 1 | 2002 | 999 | 0.010 |
Why?
|
Pain | 1 | 2015 | 5077 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2012 | 4040 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2010 | 8102 | 0.010 |
Why?
|
Capsaicin | 1 | 2000 | 226 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2013 | 7599 | 0.010 |
Why?
|
Ultrasonography | 1 | 2012 | 5993 | 0.010 |
Why?
|
Forecasting | 1 | 2008 | 2936 | 0.010 |
Why?
|
Physical Stimulation | 1 | 2000 | 513 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 2000 | 682 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12807 | 0.010 |
Why?
|
Patient Selection | 1 | 2010 | 4255 | 0.010 |
Why?
|
Learning | 1 | 2007 | 1755 | 0.010 |
Why?
|
Medically Uninsured | 1 | 2002 | 838 | 0.010 |
Why?
|
Diet | 1 | 2015 | 8086 | 0.010 |
Why?
|
Population Surveillance | 1 | 2007 | 2590 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2008 | 3564 | 0.010 |
Why?
|
Animals | 3 | 2013 | 168764 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2013 | 22332 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2010 | 18973 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2012 | 4873 | 0.010 |
Why?
|
Decision Making | 1 | 2008 | 3965 | 0.010 |
Why?
|
Rats | 1 | 2010 | 23707 | 0.010 |
Why?
|
Heart Diseases | 1 | 2006 | 2821 | 0.010 |
Why?
|
Social Support | 1 | 2002 | 2192 | 0.010 |
Why?
|
Health Behavior | 1 | 2002 | 2650 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2010 | 26346 | 0.010 |
Why?
|
Child, Preschool | 1 | 2012 | 42500 | 0.010 |
Why?
|
Pregnancy | 1 | 2010 | 30260 | 0.000 |
Why?
|